Flowr” or the “
Company”) announces the granting of incentive stock options to purchase 6,496,000 common shares in the capital of the Company (the “
Options”) and 2,970,000 restricted share units (the “
RSUs”) to certain employees, officers and directors of the Company, subject to regulatory approval. The Options and RSUs were granted on February 8, 2021 pursuant to the Company’s applicable incentive plans. The Options are exercisable at a price of $0.44 per share and are set to expire on February 12, 2026. The Options and RSUs vest as follow: (a) one-third on the first anniversary of when the Options and RSUs were granted; (b) one-third on the second anniversary of when the Options and RSUs were granted; and (c) the remaining one-third on the third anniversary of when the Options and RSUs were granted. Notwithstanding the foregoing, 2,106,949 RSUs shall vest immediately and are subject to certain vesting periods.
Article content
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
TORONTO, Feb. 10, 2021 (GLOBE NEWSWIRE) The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“
Flowr” or the “
Company”) is pleased to announce that it has entered into an agreement with Cantor Fitzgerald Canada Corporation as sole bookrunner and lead underwriter (the “
Lead Underwriter”) pursuant to which the Lead Underwriter has agreed, on behalf of a syndicate of underwriters (collectively, the “
Underwriters”), to purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate of 19,610,000 units of the Company (the “
Flowr” or the “
Company”) provides commentary on the decision by INFARMED, I.P. (“
INFARMED”), Portugal’s National Authority of Medicines and Health Products, to approve the first market authorization which will allow a licensed producer of medical cannabis to release products in Portugal.
“We applaud the decision by INFARMED, which was the first of its kind, to allow patients to have access to medical cannabis products in Portugal through indication-specific market authorizations. The Portuguese government is forward thinking in its approach to improving the quality of life for Portuguese patients as scientific data continues to mount regarding medical cannabis as both safe and efficacious in treating a variety of conditions,” commented Pauric Duffy, Flowr’s Managing Director of Europe. “This ground-breaking decision sets the stage for Flowr to pursue market authorizations to serve Portuguese and European patients with medical cannabis produced from our world
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
The Flowr Corporation Wins Brand of the Year at ADCANN & Continues to Win Additional Awards
The Flowr CorporationJanuary 28, 2021 GMT
Flowr wins Brand of the Year and Campaign of the Year at the 2020 ADCANN awards.
The Company’s agency of record, Zerotrillion, was awarded Agency of the Year at the ADCANN 2020 awards for its work on Flowr’s brand. Flowr also won a Bronze award at the 2020 Clio Cannabis Awards for its BC Pink Kush campaign.
TORONTO, Jan. 27, 2021 (GLOBE NEWSWIRE) The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) has begun 2021 with three wins at the ADCANN Awards - including the coveted Brand of The Year award. The annual awards, which are voted on by the public, exist to celebrate the best marketing and advertising across Canada’s growing cannabis industry. Alongside the Brand of The Year Award, Flowr also won Campaign of the
The Flowr Corporation Announces Private Placement wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.